In March 2025, the company introduced new designs for any immediate-to-purchaser offering of its Wegovy weight loss drug. The company proven a completely new pharmacy, known as NovoCare, which would demand consumers $499 per 30 days for usage of the drug, fewer than fifty percent the cost of the drug through other pharmaceutical distribution networ